Stock listing

NASDAQ:IART Integra LifeSciences Holdings Corporation Stock

Home listing (NASDAQ) of Integra LifeSciences Holdings Corporation

Follow Integra LifeSciences Holdings Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:IART

$13.25 USD -0.61 (-4.4%)

Close on Nov 20, 2026

Past year +19.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$13.16 – $13.79 USDNov 20, 2026
Volume
826,614 sharesNov 20, 2026
Market cap
$1.03B USDAt the close on Nov 20, 2026 · price × 77.80M shares outstanding
52-week range
$8.70 – $20.49 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$14.79M USDMedian day 998,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Integra LifeSciences Holdings Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:IART · Home$13.25 USD-0.61 (-4.4%)826,614$13.38$13.79$13.16$13.86Close on Nov 20, 2026
Munich:IL3€12.40 EUR-0.20 (-1.6%)—€12.40€12.40€12.40€12.60Close on Nov 20, 2026
Frankfurt:IL3€12.10 EUR-0.20 (-1.6%)—€12.10€12.10€12.10€12.30Close on Nov 20, 2026
Stuttgart:IL3€12.50 EUR+0.20 (+1.6%)—€13.00€13.30€12.20€12.30Close on Nov 5, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:IART · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$13.25-0.61-4.4%$13.38$13.79$13.16826,614
$13.86+0.31+2.3%$13.40$13.94$13.40575,006
$13.55-0.43-3.1%$13.82$13.88$13.401,169,745
$13.98-0.42-2.9%$14.30$14.52$13.94706,376
$14.40+0.05+0.3%$14.42$14.58$14.15648,836
$14.35-0.42-2.8%$14.62$14.93$14.131,071,197
$14.77+0.24+1.7%$14.55$15.07$14.391,000,165
$14.53+0.16+1.1%$14.37$14.76$13.781,770,753
$14.37+0.95+7.1%$13.66$14.40$13.421,035,800
$13.42-0.70-5.0%$13.94$14.13$13.32871,884
$14.12-0.70-4.7%$14.87$15.25$13.73992,058
$14.82+1.19+8.7%$13.97$15.15$13.841,174,233
$13.63+0.02+0.1%$13.69$13.74$13.431,693,410
$13.61+0.86+6.7%$12.98$13.97$12.981,504,288
$12.75-0.08-0.6%$12.74$12.85$12.341,038,769
$12.83+0.59+4.8%$12.43$13.01$12.281,188,112
$12.24+0.25+2.1%$11.98$12.33$11.931,789,006
$11.99-0.11-0.9%$12.25$12.25$11.721,431,835
$12.10+0.19+1.6%$12.05$12.24$12.00916,421
$11.91-0.415-3.4%$12.12$12.40$11.821,212,688
$12.33+0.485+4.1%$11.69$12.36$11.661,386,962
$11.84-1.49-11.2%$12.77$13.75$11.572,017,659
$13.33-0.12-0.9%$13.51$13.76$13.271,308,014
$13.45+0.24+1.8%$13.13$13.49$13.11726,141
$13.21-0.32-2.4%$13.65$13.83$13.10831,000
$13.53+0.35+2.7%$13.38$13.64$13.291,334,200
$13.18-0.67-4.8%$13.45$13.79$12.921,105,400
$13.85-0.13-0.9%$14.05$14.28$13.66818,800
$13.98+0.54+4.0%$13.43$14.03$13.42893,700
$13.44+0.03+0.2%$13.38$13.86$13.231,228,100
$13.41+0.41+3.2%$12.86$13.44$12.831,459,600
$13.00-0.32-2.4%$13.19$13.46$12.981,408,500
$13.32+0.03+0.2%$13.46$13.51$12.881,369,200
$13.29+0.61+4.8%$12.65$13.49$12.351,859,000
$12.68-3.41-21.2%$13.31$14.00$12.632,693,900
$16.09-0.19-1.2%$16.21$16.45$15.88652,900
$16.28-0.36-2.2%$16.67$16.67$16.14768,900
$16.64+0.37+2.3%$16.27$16.77$15.801,005,200
$16.27+0.15+0.9%$16.04$16.27$15.86479,000
$16.12+0.24+1.5%$15.88$16.21$15.74539,000
$15.88+0.35+2.3%$15.67$15.91$15.49759,500
$15.53-0.49-3.1%$15.88$16.26$15.38573,100
$16.02+0.43+2.8%$15.90$16.29$15.69770,500
$15.59+0.37+2.4%$15.06$15.65$14.911,064,200
$15.22+0.12+0.8%$14.98$15.24$14.882,169,100
$15.10-0.96-6.0%$16.30$16.38$15.071,051,300
$16.06+0.37+2.4%$15.81$16.22$15.651,618,100
$15.69-0.02-0.1%$15.69$16.04$15.201,077,600
$15.71+0.21+1.4%$15.36$15.80$15.361,141,800
$15.50-0.04-0.3%$16.06$16.22$15.33792,000
$15.54-0.71-4.4%$15.93$16.04$15.391,362,000
$16.25-0.01-0.1%$16.10$16.46$15.99578,400
$16.26-0.46-2.8%$16.48$16.55$15.99621,800
$16.72+0.28+1.7%$16.32$16.78$16.25674,300
$16.44-0.37-2.2%$17.09$17.11$16.28998,500
$16.81+0.19+1.1%$16.80$17.21$16.66528,900
$16.62-0.30-1.8%$16.84$17.08$16.54559,700
$16.92+0.03+0.2%$16.81$16.95$16.48581,100
$16.89+0.04+0.2%$16.97$17.33$16.87776,200
$16.85-0.03-0.2%$16.85$17.17$16.79449,800
$16.88+0.09+0.5%$16.85$17.10$16.62489,400
$16.79+0.10+0.6%$16.73$16.87$16.39369,500
$16.69-0.05-0.3%$16.74$17.00$16.39654,700
$16.74+0.15+0.9%$16.81$16.94$16.44551,000
$16.59-0.65-3.8%$17.01$17.47$16.56582,300

Splits

2 splits since 1998 · NASDAQ:IART · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
1-for-2Consolidation
Ticker
NASDAQ:IART
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Integra LifeSciences Holdings Corporation news

Integra LifeSciences Holdings Corporation on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
33 in the last 12 months · 148 in all · newest Nov 6, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Oct 2, 2026
Decks
40 decks · latest Oct 21, 2026

Where Integra LifeSciences Holdings Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:IART · Home listing · This pageNASDAQUnited StatesUSD
LS Exchange:897013LS ExchangeGermanyEUR
Lang & Schwarz:897013Lang & SchwarzGermanyEUR
gettex:IL3gettexGermanyEUR
BOATS:IARTBOATSUnited StatesUSD
Munich:IL3MunichGermanyEUR
BX Swiss:IL3BX SwissSwitzerlandCHF
Dusseldorf:IL3DusseldorfGermanyEUR
Frankfurt:IL3FrankfurtGermanyEUR
Stuttgart:IL3StuttgartGermanyEUR
Tradegate:IL3TradegateGermanyEUR

Valuation

P/E 79.2× against a median of 22.8×: 6th lowest of 7 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.42B USD
P/E
79.2×
EV/sales
0.8×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
1.0×
Gross margin
52.4%
Operating margin
4.4%
Net margin
0.8%
Debt to equity
0.7×
Beta vs S&P 500
1.47

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Integra LifeSciences Holdings Corporation · NASDAQ:IARTUS$1.03BUS$1.42B79.2×0.8×n/a1.0×0.8%0.7×1.47
Shandong Weigao Orthopaedic Device Co., Ltd. Class A · SSE:688161US$1.09BUS$897.1M30.3×4.3×n/a1.7×17.2%0.0×n/a
SI-BONE, Inc. · NASDAQ:SIBNUS$1.07BUS$1.07Bn/a4.8×n/a5.8×−6.2%0.2×0.62
CeriBell, Inc. · NASDAQ:CBLLUS$1.06BUS$967.9Mn/a8.9×n/a9.1×−68.0%0.2×0.82
CLASSYS Inc. · KRX:214150US$1.06BUS$959.6M10.3×3.5×7.0×2.6×37.3%0.0×n/a
Shinva Medical Instrument Co. Ltd. Class A · SSE:600587US$1.04BUS$608.1M15.3×0.4×n/a0.9×4.5%0.0×n/a
Alphatec Holdings, Inc. · NASDAQ:ATECUS$1.04BUS$1.51Bn/a1.8×31.6×n/a−10.3%n/a1.26
iRadimed Corporation · NASDAQ:IRMDUS$1.04BUS$972.8M43.2×10.9×31.9×9.7×26.9%0.0×0.65
Draegerwerk AG & Co. KGaA · XETR:DRW8US$986.0MUS$911.4M5.3×0.2×2.0×0.5×4.7%0.1×n/a
Shenzhen Edge Medical Co., Ltd. Class H · HKEX:2675US$973.1MUS$695.5Mn/a10.2×n/a2.8×−19.4%0.0×n/a
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A · SZSE:301234US$952.4MUS$890.2M354×14.4×n/a8.3×4.3%0.0×n/a
Median of the othersUS$1.04BUS$935.5M22.8×4.6×19.3×2.8×4.4%0.0×0.74

Forecasts

2 strong buy · 1 buy · 7 hold · 2 sell · Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.

Price target
15.67 USD · Analysts' mean
EPS, year to Dec 2026
2.34 · 12 analysts
Revenue, year to Dec 2026
1.64B · 11 analysts

Team and board

Officers

OfficerRole
Stuart Essigpresident and chief executive officer, Chairman
Lea Daniels KnightExecutive Vice President and Chief Financial Officer
Christopher Kilburn-PetersonCorporate Vice President and President, Tissue Reconstruction
Harvinder SinghExecutive Vice President and President, Specialty Surgery
Jeff GravesPresident, 3D Systems Corporation
Robert T. DavisExecutive Vice President and President, Tissue Reconstruction and Distributed Technologies
Lesha ShinnCorporate Vice President, Chief Legal Officer and Company Secretary
Chris WardInvestor Relations
Andrea CarusoCorporate Vice President and Chief Human Resources Officer
Dimitri KvaresCorporate Vice President and Chief Information Officer
Kerri DiPietroCorporate Vice President and Chief Quality Officer
Michael McBreenExecutive Vice President and Chief Commercial Officer
Raymond TurnerCorporate Vice President and Chief Medical Officer
Rick MaveusSenior Vice President, Transformation and Program Management Office
Teshtar ElaviaCorporate Vice President and Chief Technology Officer
Topaz Joy KirlewCorporate Vice President and Chief Regulatory Officer
Valerie YoungCorporate Vice President, Global Supply Chain
Renee LoVice President APAC, Sales Solutions for LinkedIn Corporation; Chair of the Compensation Committee

Board

DirectorRole
Stuart Essigpresident and chief executive officer, Chairman

Events

Calls

CallWhenStatus
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2026 Earnings CallFri, Oct 02, 2026 · 5:00 PM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q2 2026 Earnings CallWed, Jul 29, 2026 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q1 2026 Earnings CallTue, May 05, 2026 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q4 2025 Earnings CallThu, Feb 26, 2026 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2025 Earnings CallThu, Oct 30, 2025 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q2 2025 Earnings CallThu, Jul 31, 2025 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q1 2025 Earnings CallMon, May 05, 2025 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q4 2024 Earnings CallTue, Feb 25, 2025 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2024 Earnings CallMon, Nov 04, 2024 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q2 2024 Earnings CallMon, Jul 29, 2024 · 8:30 AM ETReplay
All 23 calls
CallWhenStatus
Integra LifeSciences Holdings (NASDAQ:IART) Q1 2024 Earnings CallMon, May 06, 2024 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q4 2023 Earnings CallWed, Feb 28, 2024 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2023 Earnings CallWed, Oct 25, 2023 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q2 2023 Earnings CallThu, Jul 27, 2023 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q1 2023 Earnings CallWed, Apr 26, 2023 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q4 2022 Earnings CallWed, Feb 22, 2023 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2022 Earnings CallWed, Oct 26, 2022 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q2 2022 Earnings CallWed, Jul 27, 2022 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q1 2022 Earnings CallWed, Apr 27, 2022 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q4 2021 Earnings CallWed, Jan 12, 2022 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q3 2021 Earnings CallTue, Nov 02, 2021 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q2 2021 Earnings CallWed, Jul 28, 2021 · 8:30 AM ETReplay
Integra LifeSciences Holdings (NASDAQ:IART) Q1 2021 Earnings CallWed, Apr 28, 2021 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 21, 2026 · Before open−11.2%
Q2 2026Jul 29, 2026 · Before open−16.6%
Q1 2026May 5, 2026 · Before open+24.1%
Q4 2025Feb 26, 2026−1.8%
Q3 2025Oct 30, 2025 · Before open−23.5%
Q2 2025Jul 31, 2025 · Before open+6.2%
Q1 2025May 5, 2025 · Before open−21.2%
Q4 2024Feb 26, 2025 · Before open−4.5%
Q3 2024Nov 4, 2024 · Before open+25.1%
Q2 2024Jul 29, 2024 · Before open−19.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 6, 2024 · Before open−19.9%
Q4 2023Feb 28, 2024 · Before open−12.7%
Q3 2023Oct 25, 2023 · Before open−5.0%
Q2 2023Jul 26, 2023 · After close−2.2%
Q1 2023Apr 26, 2023 · Before open−7.9%
Q4 2022Feb 22, 2023 · Before open−1.2%
Q3 2022Oct 26, 2022 · Before open+5.8%
Q2 2022Jul 27, 2022 · Before open−1.1%
Q1 2022Apr 27, 2022 · Before open+2.4%
Q4 2021Feb 23, 2022 · Before open−1.1%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings19 slidesOct 21, 2026
Investor Presentation (September 2026)Investor deck54 slidesSep 8, 2026
Q2 2026 Earnings PresentationEarnings19 slidesJul 29, 2026
Q1 2026 Earnings PresentationEarnings19 slidesMay 5, 2026
Q4 2025 Earnings PresentationEarnings22 slidesFeb 26, 2026
J.P. Morgan Healthcare Conference 2026Conference14 slidesJanuary 2026
Q3 2025 Earnings PresentationEarnings19 slidesOct 30, 2025
Q2 2025 Earnings PresentationEarnings19 slidesJul 31, 2025
Q1 2025 Earnings PresentationEarnings19 slidesMay 5, 2025
Q4 2024 Earnings PresentationEarnings21 slidesFeb 25, 2025
All 40 decks
DeckKindSlidesDate
Q3 2024 Earnings PresentationEarnings21 slidesNov 4, 2024
Q2 2024 Earnings PresentationEarnings19 slidesJul 29, 2024
Q1 2024 Earnings PresentationEarnings19 slidesMay 6, 2024
Q4 2023 Earnings PresentationEarnings21 slidesFeb 28, 2024
2024 JP Morgan Healthcare ConferenceConference17 slidesJanuary 2024
Merger or Acquisition (December 2023)Merger or acquisition12 slidesDec 13, 2023
Q3 2023 Earnings PresentationEarnings21 slidesOct 25, 2023
Q2 2023 Earnings PresentationEarnings22 slidesJul 27, 2023
Investor Day (May 2023)Investor day94 slidesMay 4, 2023
Q1 2023 Earnings PresentationEarnings20 slidesApr 26, 2023
FY2022 Earnings PresentationEarnings24 slidesFeb 22, 2023
2023 JP Morgan Healthcare ConferenceConference20 slidesJan 10, 2023
Merger or Acquisition (December 2022)Merger or acquisition10 slidesDec 1, 2022
Q1 2022 Earnings PresentationEarnings19 slidesApr 27, 2022
FY2021 Earnings PresentationEarnings26 slidesFeb 23, 2022
Q3 2021 Earnings PresentationEarnings22 slidesNov 2, 2021
Q1 2017 Earnings PresentationEarnings18 slidesApr 26, 2017
Q4 2016 Earnings PresentationEarnings22 slidesFeb 23, 2017
Merger or Acquisition (February 2017)Merger or acquisition26 slidesFeb 15, 2017
Merger or Acquisition (January 2017)Merger or acquisition7 slidesJan 11, 2017
Q3 2017 Earnings PresentationEarnings20 slides2017
Q2 2016 Earnings PresentationEarnings21 slidesJul 28, 2016
Q2 2015 Earnings PresentationEarnings23 slidesJul 30, 2015
Jefferies' 2015 Global Healthcare ConferenceConference23 slidesJune 2015
Corporate Update (April 2015)Corporate update7 slidesApr 13, 2015
Investor Presentation (2015)Investor deck35 slides2015
Investor Presentation (November 2014)Investor deck23 slidesNov 13, 2014
Q1 2009 Earnings PresentationEarnings15 slidesMay 6, 2009
Investor PresentationInvestor deck24 slides
Investor PresentationInvestor deck33 slides

Open Decks

Financings

RaiseDate
9.500% senior secured notes due 2033
Closed: US$450M raised
Use of proceeds: With credit facility borrowings, to refinance its existing credit facility and pay related fees and expenses
Oct 19, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.64B1.61B1.54B1.56B1.54B1.37B1.52B1.47B1.19B992.1M
Cost of revenue803.6M728.5M656.8M587.4M597.8M520.8M564.7M571.5M435.5M349.1M
Gross profit831.6M882.1M884.7M970.3M944.6M851.0M952.9M900.9M752.7M643.0M
Research and development99.0M115.4M104.2M101.2M93.1M77.4M79.6M78.0M63.5M58.2M
Selling, general and administrative699.7M717.0M656.6M616.3M637.4M594.5M687.6M690.7M624.1M455.6M
Operating income-493.4M28.4M111.5M238.9M197.2M151.4M93.8M111.0M44.8M115.3M
Depreciation and amortization44.8M42.4M40.9M40.1M39.4M42.1M109.5M110.7M88.9M72.7M
EBITDA-448.6M70.8M152.4M279.0M236.6M193.5M203.2M221.7M133.7M188.0M
Interest expense86.3M70.6M51.4M49.6M50.4M71.6M54.0M64.7M35.0M25.8M
Income before tax-563.5M-18.2M81.1M213.9M214.7M93.5M60.1M57.4M11.4M90.4M
Income tax-47.0M-11.3M13.3M33.3M45.6M-40.4M9.90M-3.40M-53.4M15.8M
Net income-516.5M-6.94M67.7M180.6M169.1M133.9M50.2M60.8M64.7M74.6M
Earnings per share, basic-6.74-0.090.852.182.001.580.590.730.841.00
Earnings per share, diluted-6.74-0.090.842.161.981.570.580.720.820.94

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents235.0M246.4M276.4M456.7M513.4M470.2M198.9M138.8M174.9M102.1M
Short-term investments28.7M27.2M32.7M00
Receivables278.8M272.4M259.3M263.5M231.8M225.5M275.3M265.7M251.8M148.2M
Inventory492.7M429.1M389.6M324.6M317.4M310.1M316.1M280.3M296.3M217.3M
Current assets1.16B1.08B1.06B1.16B1.15B1.24B858.2M775.1M822.1M495.2M
Property, plant and equipment444.3M405.7M340.2M311.3M311.7M287.5M337.4M300.1M269.3M222.4M
Goodwill615.2M1.10B1.06B1.04B1.01B932.4M954.3M926.5M937.9M510.6M
Total assets3.60B4.04B3.78B3.89B3.78B3.62B3.30B3.11B3.21B1.81B
Current liabilities456.0M922.1M307.0M320.9M340.0M401.0M331.3M262.6M348.9M123.6M
Total debt726.6M760.5M775.0M775.0M843.8M877.5M877.5M900.0M
Total liabilities2.56B2.49B2.19B2.09B2.10B2.10B1.89B1.73B2.25B968.3M
Shareholders' equity1.04B1.55B1.59B1.80B1.68B1.51B1.42B1.38B962.3M839.7M
Shares outstanding77.8M77.8M77.9M77.9M77.2M78.2M81.6M83.2M84.4M84.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations50.4M129.4M140.0M264.5M312.4M203.8M231.4M199.7M114.5M116.4M
Capital spending-81.4M-104.4M-66.9M-42.3M-48.0M-38.9M-69.5M-77.7M-43.5M-47.3M
Free cash flow-31.1M25.0M73.1M222.1M264.4M164.9M161.9M121.9M71.0M69.1M
Cash from investing-108.1M-390.8M-94.2M-58.6M-161.4M-68.1M-162.7M-49.7M-1.22B-42.6M
Cash from financing28.3M237.9M-229.9M-252.0M-98.2M121.6M-8.77M-180.9M1.17B-15.1M
Share buybacks-221.0K-52.5M-275.0M-125.0M0-100.0M00
Change in cash-11.3M-30.0M-180.3M-56.8M43.3M271.3M60.1M-36.1M72.9M53.9M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
10-Q · Quarterly reportOct 23, 2026Quarterly reportSEC
8-K · Current reportOct 21, 2026ResultsSEC
8-K · Current reportOct 19, 2026Material contractSEC
3 · Initial statement of ownershipOct 13, 2026Insider tradeSEC
8-K · Current reportOct 9, 2026Current reportSEC
8-K · Current reportOct 2, 2026ResultsSEC
3 · Initial statement of ownershipSep 28, 2026Insider tradeSEC
8-K · Current reportSep 8, 2026Current reportSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJul 31, 2026Big-stake noticeSEC
10-Q · Quarterly reportJul 29, 2026Quarterly reportSEC
8-K · Current reportJul 29, 2026ResultsSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMay 8, 2026Offer documentSEC
8-K · Current reportMay 8, 2026Management or board changeSEC
10-Q · Quarterly reportMay 5, 2026Quarterly reportSEC
DEFA14A · Additional proxy materialMay 5, 2026Meeting noticeSEC
8-K · Current reportMay 5, 2026Management or board changeSEC
8-K · Current reportMay 5, 2026ResultsSEC
8-K · Current reportApr 15, 2026Material contractSEC
DEF 14A · Proxy statementApr 6, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
S-3ASR · Registration statementFeb 26, 2026Offer documentSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipJan 7, 2026Insider tradeSEC
8-K · Current reportDec 12, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 6, 2025Big-stake noticeSEC
4 · Change in ownershipNov 6, 2025Insider tradeSEC
10-Q · Quarterly reportOct 30, 2025Quarterly reportSEC
8-K · Current reportOct 30, 2025ResultsSEC
4 · Change in ownershipOct 14, 2025Insider tradeSEC
4 · Change in ownershipSep 2, 2025Insider tradeSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 5, 2025Big-stake noticeSEC
S-8 · Registration statement for employee plansJul 31, 2025Offer documentSEC
10-Q · Quarterly reportJul 31, 2025Quarterly reportSEC
8-K · Current reportJul 31, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 17, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 9, 2025Big-stake noticeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
8-K · Current reportJun 9, 2025Material contractSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
SCHEDULE 13G · Big-stake noticeMay 14, 2025Big-stake noticeSEC
8-K · Current reportMay 13, 2025Management or board changeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 9, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 5, 2025Quarterly reportSEC
8-K · Current reportMay 5, 2025ResultsSEC
DEF 14A · Proxy statementApr 4, 2025Meeting noticeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
10-K · Annual reportFeb 25, 2025Annual reportSEC
8-K · Current reportFeb 25, 2025ResultsSEC
4 · Change in ownershipJan 8, 2025Insider tradeSEC
3 · Initial statement of ownershipJan 7, 2025Insider tradeSEC
8-K · Current reportJan 6, 2025Current reportSEC
8-K · Current reportDec 17, 2024Management or board changeSEC
4 · Change in ownershipDec 4, 2024Insider tradeSEC
144 · Notice of proposed saleDec 3, 2024Other filingsSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
SC 13G · Big-stake noticeNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansNov 4, 2024Offer documentSEC
4 · Change in ownershipNov 4, 2024Insider tradeSEC
10-Q · Quarterly reportNov 4, 2024Quarterly reportSEC
8-K · Current reportNov 4, 2024ResultsSEC
8-K · Current reportNov 4, 2024Management or board changeSEC
4 · Change in ownershipSep 3, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedAug 12, 2024Big-stake noticeSEC
10-Q · Quarterly reportJul 29, 2024Quarterly reportSEC
8-K · Current reportJul 29, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedJul 8, 2024Big-stake noticeSEC
4 · Change in ownershipJul 5, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
SD · Specialized disclosureMay 30, 2024ESG reportSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
8-K · Current reportMay 16, 2024Current reportSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
8-K · Current reportMay 13, 2024Management or board changeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
10-Q · Quarterly reportMay 6, 2024Quarterly reportSEC
8-K · Current reportMay 6, 2024ResultsSEC
ARS · Annual report to shareholdersApr 4, 2024Annual reportSEC
DEF 14A · Proxy statementApr 4, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementMar 25, 2024Meeting noticeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 13, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 12, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
144 · Notice of proposed saleMar 6, 2024Other filingsSEC
10-K · Annual reportFeb 28, 2024Annual reportSEC
8-K · Current reportFeb 28, 2024Management or board changeSEC
8-K · Current reportFeb 28, 2024ResultsSEC
8-K/A · Current report, amendedFeb 27, 2024Management or board changeSEC
4 · Change in ownershipFeb 22, 2024Insider tradeSEC
4 · Change in ownershipFeb 22, 2024Insider tradeSEC
4 · Change in ownershipFeb 22, 2024Insider tradeSEC
4 · Change in ownershipFeb 22, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 9, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 25, 2024Big-stake noticeSEC
4 · Change in ownershipJan 19, 2024Insider tradeSEC
8-K · Current reportDec 20, 2023Material contractSEC
4 · Change in ownershipDec 13, 2023Insider tradeSEC
3 · Initial statement of ownershipDec 13, 2023Insider tradeSEC
8-K · Current reportDec 13, 2023Management or board changeSEC
8-K · Current reportDec 13, 2023Material contractSEC
4 · Change in ownershipNov 3, 2023Insider tradeSEC
10-Q · Quarterly reportOct 25, 2023Quarterly reportSEC
8-K · Current reportOct 25, 2023ResultsSEC
4/A · Change in ownership, amendedOct 13, 2023Insider tradeSEC
4 · Change in ownershipSep 5, 2023Insider tradeSEC
3 · Initial statement of ownershipSep 5, 2023Insider tradeSEC
8-K · Current reportAug 15, 2023Current reportSEC
4 · Change in ownershipAug 10, 2023Insider tradeSEC
144 · Notice of proposed saleAug 9, 2023Other filingsSEC
10-Q · Quarterly reportJul 27, 2023Quarterly reportSEC
8-K · Current reportJul 26, 2023ResultsSEC
4 · Change in ownershipJul 6, 2023Insider tradeSEC
4 · Change in ownershipJul 6, 2023Insider tradeSEC
3 · Initial statement of ownershipJul 6, 2023Insider tradeSEC
8-K · Current reportJun 21, 2023Management or board changeSEC
4 · Change in ownershipJun 5, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
SD · Specialized disclosureMay 31, 2023ESG reportSEC
8-K · Current reportMay 23, 2023Current reportSEC
8-K · Current reportMay 16, 2023Meeting outcomeSEC
4 · Change in ownershipMay 16, 2023Insider tradeSEC
4 · Change in ownershipMay 16, 2023Insider tradeSEC
4 · Change in ownershipMay 16, 2023Insider tradeSEC
4 · Change in ownershipMay 16, 2023Insider tradeSEC
4 · Change in ownershipMay 16, 2023Insider tradeSEC
4 · Change in ownershipMay 16, 2023Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Integra LifeSciences Holdings Corporation’s releases · as of Oct 22, 2026

Common shares
77,800,976
Fully diluted
77,800,976

Fully diluted

LineSharesAs of
Common shares77,800,976Oct 22, 2026

Share count over time

CountShares
Oct 22, 202677,800,976

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock10.8M13.9%US$176M+142KNov 13, 2026
Vanguard7.54M9.7%US$123M+169KNov 13, 2026
Rubric Capital Management LP7.35M9.5%US$120M−400KNov 16, 2026
Invesco4.16M5.4%US$67.8M+415KNov 12, 2026
Morgan Stanley3.74M4.8%US$60.9M+148KNov 13, 2026
Paradigm Capital Management Inc3.1M4.0%US$50.4M−342KNov 13, 2026
State Street3.02M3.9%US$49.2M+72,956Nov 12, 2026
Dimensional2.77M3.6%US$45M+549KNov 4, 2026
Fuller & Thaler Asset Management, Inc.2.21M2.8%US$35.9M−1.23MNov 13, 2026
Neuberger Berman Group LLC2.06M2.7%US$33.6M−301KNov 13, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Geode Capital1.73M2.2%US$28.2M−57,327Nov 6, 2026
Bank of America1.65M2.1%US$26.9M+326KNov 16, 2026
Goldman Sachs1.58M2.0%US$25.7M+107KNov 16, 2026
Schwab1.44M1.9%US$23.5M+43,438Nov 16, 2026
Wellington1.18M1.5%US$19.2M−282KNov 16, 2026
Allianz1.07M1.4%US$17.5M+69,160Nov 16, 2026
Systematic Financial Management LP1.03M1.3%US$16.8M+11,542Nov 16, 2026
Glenmede Trust Co NA850K1.1%US$12.3M−97,939Nov 16, 2026
Northern Trust805K1.0%US$13.1M−23,883Nov 16, 2026
Nuveen744K0.96%US$12.1M+258KNov 10, 2026
Quantinno Capital Management LP731K0.94%US$11.9M+122KNov 13, 2026
Lsv Asset Management718K0.92%US$11.7M+500KNov 6, 2026
Balyasny Asset Management L.P.653K0.84%US$10.6M+12,210Nov 16, 2026
Invenomic Capital Management LP649K0.83%US$10.6M+70,433Nov 16, 2026
JPMorgan606K0.78%US$10.1M+392KNov 12, 2026
PFM Health Sciences, LP579K0.74%US$9.43M+230KNov 16, 2026
Access Investment Management LLC565K0.73%US$9.2M+160KOct 23, 2026
Citadel544K0.70%US$8.86MNewNov 16, 2026
D. E. Shaw & Co., Inc.543K0.70%US$8.84M+35,881Nov 16, 2026
BNY471K0.61%US$7.67M−14,376Nov 5, 2026
Millennium430K0.55%US$7.01M−1.01MNov 16, 2026
AQR Capital Management LLC407K0.52%US$6.62M+148KNov 16, 2026
Legal & General402K0.52%US$6.54M+72,244Nov 16, 2026
Leeward Investments, LLC - MA329K0.42%US$5.35M−21,592Oct 23, 2026
Raymond James Financial Inc327K0.42%US$5.32M+52,270Nov 12, 2026
Arrowstreet Capital, Limited Partnership324K0.42%US$5.27M+192KNov 13, 2026
Principal316K0.41%US$5.15M−7,333Nov 2, 2026
UBS314K0.40%US$5.11M+21,154Nov 16, 2026
Kennedy Capital Management LLC251K0.32%US$4.08MNewNov 13, 2026
Public Sector Pension Investment Board225K0.29%US$3.13M−5,046Nov 10, 2026
Franklin Templeton217K0.28%US$3.22M−13,149Nov 12, 2026
BNP Paribas188K0.24%US$3.06M+160KNov 12, 2026
Russell Investments Group, Ltd.170K0.22%US$2.77M+134KNov 6, 2026
Rhumbline Advisers167K0.21%US$2.72M−4,267Nov 10, 2026
American Century166K0.21%US$2.7M+19,006Nov 20, 2026
Susquehanna165K0.21%US$2.68M−20,798Nov 16, 2026
Campbell & CO Investment Adviser LLC164K0.21%US$2.66MNewNov 13, 2026
Commonwealth Equity Services, LLC153K0.20%US$2.49M+2,889Nov 2, 2026
Two Sigma149K0.19%US$2.42M−36,098Nov 16, 2026
Universal- Beteiligungs- und Servicegesellschaft mbH147K0.19%US$2.4M+69,901Nov 10, 2026

This page holds 50 of 225 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
iShares Core S&P Small-Cap ETF4.03M5.2%US$72.4M+13,856Jun 30, 2026
Invesco Small Cap Value Fund3.39M4.4%US$56.4MNo changeJul 31, 2026
Undiscovered Managers Behavioral Value Fund2.82M3.6%US$50.7M−106KJun 30, 2026
Vanguard Total Stock Market Index Fund2.11M2.7%US$37.9M+29,100Jun 30, 2026
iShares Russell 2000 ETF1.78M2.3%US$32M+138KJun 30, 2026
Vanguard Small-Cap Index Fund1.52M1.9%US$27.2M−6,535Jun 30, 2026
Vanguard Small-Cap Value Index Fund961K1.2%US$17.3M−12,302Jun 30, 2026
Small Cap Equity Portfolio840K1.1%US$14M−50,528Jul 31, 2026
Vanguard Extended Market Index Fund770K0.99%US$13.8M+23,620Jun 30, 2026
Fidelity Small Cap Index Fund748K0.96%US$12.5M+87,210Jul 31, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Schwab Fundamental U.S. Small Company ETF668K0.86%US$10.7M−115KMay 31, 2026
PIMCO RAE US Small Fund651K0.84%US$11.7M+31,691Jun 30, 2026
iShares Russell 2000 Value ETF637K0.82%US$11.4M+63,145Jun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF614K0.79%US$11M+3,771Jun 30, 2026
iShares S&P Small-Cap 600 Value ETF576K0.74%US$10.3M−78,668Jun 30, 2026
Neuberger Intrinsic Value Fund560K0.72%US$8.98M−428May 31, 2026
U.S. Small Cap Value Portfolio479K0.62%US$7.97M+96,791Jul 31, 2026
Vanguard Explorer Value Fund446K0.57%US$7.15M+2,578May 31, 2026
Paradigm Micro-Cap Fund400K0.51%US$7.18M−100KJun 30, 2026
Invenomic Fund395K0.51%US$6.57M−338KJul 31, 2026
Fidelity Extended Market Index Fund350K0.45%US$5.62M−59,561May 31, 2026
Vanguard Russell 2000 Index Fund344K0.44%US$5.52M+11,798May 31, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF343K0.44%US$6.15M−7,219Jun 30, 2026
Dimensional US Small Cap Value ETF342K0.44%US$5.7M−1,413Jul 31, 2026
Schwab U.S. Small-Cap ETF320K0.41%US$5.13M−5,014May 31, 2026
iShares U.S. Medical Devices ETF313K0.40%US$5.63M+25,237Jun 30, 2026
Hartford Small Cap Value Fund288K0.37%US$4.79MNo changeJul 31, 2026
U.S. Small Cap Portfolio244K0.31%US$4.06M+183Jul 31, 2026
Vanguard S&P Small-Cap 600 Index Fund231K0.30%US$3.71M+1,858May 31, 2026
U.S. Micro Cap Portfolio202K0.26%US$3.36M+63,238Jul 31, 2026
Vanguard Health Care Index Fund198K0.25%US$3.18M−1,678May 31, 2026
Invesco S&P SmallCap 600 Revenue ETF189K0.24%US$3.04M+53,006May 31, 2026
Schwab Small-Cap Index Fund166K0.21%US$2.77M+17,954Jul 31, 2026
Vanguard Tax-Managed Small-Cap Fund154K0.20%US$2.76M+61,895Jun 30, 2026
Schwab Fundamental U.S. Small Company Index Fund151K0.19%US$2.51M−27,044Jul 31, 2026
Column Small Cap Select Fund150K0.19%US$2.4M+424May 31, 2026
Vanguard S&P Small-Cap 600 Value Index Fund147K0.19%US$2.36M−322May 31, 2026
Invesco RAFI US 1500 Small-Mid ETF135K0.17%US$2.24M−12,379Jul 31, 2026
Master Small Cap Index Series128K0.16%US$2.3M+20,417Jun 30, 2026
U.S. Targeted Value Portfolio125K0.16%US$2.09M−81,830Jul 31, 2026
Fidelity Total Market Index Fund125K0.16%US$2.01MNo changeMay 31, 2026
American Beacon Small Cap Value Fund123K0.16%US$2.05MNewJul 31, 2026
NYLIM VP Wellington Small Cap Portfolio120K0.15%US$2.15M−6,007Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF114K0.15%US$2.05M−65,852Jun 30, 2026
U.S. Core Equity 1 Portfolio112K0.14%US$1.87MNewJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account109K0.14%US$1.95MNewJun 30, 2026
Avantis U.S. Small Cap Equity ETF107K0.14%US$1.72M+16,038May 31, 2026
Nuveen Small Cap Value Opportunities Fund107K0.14%US$1.92MNewJun 30, 2026
JNL Small Cap Index Fund106K0.14%US$1.9MNo changeJun 30, 2026
Fidelity Series Total Market Index Fund102K0.13%US$1.64M+1,364May 31, 2026

This page holds 50 of 240 holders. Open Shareholders

Big stakes

HolderStakeSharesDate
BlackRock, Inc.13.20%10.3MJun 30, 2025
Rubric Capital Management LP9.46%7.35MJun 30, 2025
Invesco Ltd.5.40%4.16MSep 30, 2026
Vanguard Portfolio Management LLC5.02%3.91MJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anne VanLent
Other companies: Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Novelion Therapeutics Inc (Director · Nov 29, 2016 – Dec 22, 2016 · Past); Traws Pharma, Inc. (Director · Jul 24, 2013 – Jun 15, 2015 · Past); Vaxart, Inc. (Director · May 1, 2013 – Jun 12, 2019 · Past); Aegerion Pharmaceuticals Inc (Director · Apr 26, 2013 – Nov 29, 2016 · Past); Ocera Therapeutics Inc (Director · Apr 1, 2011 – Dec 11, 2017 · Past); Barrier Therapeutics Inc (Exec VP & CFO · Mar 31, 2006 – Mar 14, 2008 · Past); Penwest Pharmaceuticals Co (Director · Jan 3, 2006 – Nov 4, 2010 · Past)
Director · May 17, 2006 – May 17, 2012 · Past
John B Henneman III
Other companies: Orthofix Medical Inc. (Director · Since at least Jan 5, 2023); Anika Therapeutics Inc. (Director · Since at least Sep 3, 2020); Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019); R1 RCM Inc (Director · Apr 3, 2017 – Nov 19, 2024 · Past); Accretive Health Inc (Director · Feb 16, 2016 – Jan 3, 2017 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past); Lumos Pharma Inc (Chief Administrative Officer · Oct 1, 2014 – Oct 1, 2018 · Past)
CorpVP, CAO · Jan 6, 2006 – Aug 25, 2014 · Past
Thomas J Baltimore Jr
Other companies: Comcast Corporation (Director · Since at least Mar 15, 2023); American Express Company (Director · Since at least Jan 27, 2021); Park Hotels & Resorts Inc. (CEO, Director · Since at least Dec 2, 2016); AutoNation, Inc. (Director · Apr 18, 2019 – Jan 4, 2021 · Past); RLJ Lodging Trust (President and CEO, Director · May 10, 2011 – May 11, 2016 · Past); Duke Realty Corporation (Director · Jan 28, 2009 – Apr 1, 2017 · Past); Prudential Financial, Inc. (Director · Oct 1, 2008 – Mar 15, 2023 · Past)
Director · Mar 5, 2007 – May 17, 2012 · Past
Jeffrey A. Graves
Other companies: 3D Systems Corporation (President and CEO · Since at least May 26, 2020); FARO Technologies Inc (Director · Dec 11, 2017 – Jun 1, 2020 · Past); MTS Systems Corporation (President and CEO, Director · May 7, 2012 – Apr 17, 2020 · Past); Hexcel Corporation (Director · Jul 12, 2007 – Oct 6, 2023 · Past); Teleflex Incorporated (Director · May 4, 2007 – May 9, 2017 · Past); C&D Technologies Inc (President & CEO, Director · Dec 23, 2005 – May 3, 2010 · Past)
Director · Since at least Dec 12, 2023
Neal Moszkowski
Other companies: J.Jill, Inc. (Director · Jun 14, 2024 – Aug 20, 2024 · Past); R1 RCM Inc (Director · Apr 3, 2017 – Nov 19, 2024 · Past); Accretive Health Inc (Director · Feb 16, 2016 – Oct 1, 2016 · Past); JetBlue Airways Corporation (Director · May 18, 2006 – Dec 2, 2008 · Past); WellCare Health Plans Inc (Director · Mar 13, 2006 – Jul 30, 2009 · Past); Bluefly Inc (Director · Feb 17, 2006 – Feb 2, 2010 · Past)
Director · Aug 1, 2006 – May 22, 2013 · Past
Stuart M. Essig
Other companies: Piper Sandler Companies (Director · Since at least Feb 4, 2026); IDEXX Laboratories, Inc. (Director · Since at least Jul 12, 2017); Orthofix Medical Inc. (Director · Jan 5, 2023 – Jan 5, 2023 · Past); Accendra Health, Inc. (Director · May 6, 2016 – Jun 28, 2019 · Past); St. Jude Medical Inc (Director · Apr 22, 2016 – Jan 4, 2017 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past)
president and chief executive officer, Chairman · Since at least Apr 4, 2016
Christian S. Schade
Other companies: Omega Therapeutics Inc (Director · Jul 10, 2023 – Jun 20, 2024 · Past); Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jul 28, 2022 · Past); Omthera Pharmaceuticals Inc (Executive VP and CFO · Apr 11, 2013 – Jul 16, 2013 · Past); NRG Energy, Inc. (Exec VP & Chief Financial Ofc · Mar 29, 2010 – Mar 29, 2011 · Past)
Director · Since at least May 17, 2006
Donald E Morel Jr
Other companies: Stevanato Group S.p.A. (Director · Since at least Mar 18, 2026); Catalent Inc (Director · Nov 13, 2015 – Dec 18, 2024 · Past); Kensey Nash Corp (Director · Mar 19, 2010 – Jun 22, 2012 · Past); West Pharmaceutical Services, Inc. (Chair of the Board & CEO · Dec 30, 2005 – Jun 30, 2015 · Past)
Director · Aug 27, 2013 – May 13, 2022 · Past
Mojdeh Poul
Other companies: Align Technology, Inc. (Director · Since at least Dec 5, 2023); iRhythm Holdings, Inc. (Director · Jun 1, 2023 – May 29, 2024 · Past); Stanley Black & Decker, Inc. (Director · Feb 18, 2021 – Mar 18, 2025 · Past); 3M Company (Group President · Jul 1, 2018 – May 17, 2022 · Past)
President & CEO, Director · Since at least Jan 6, 2025
Peter J. Arduini
Other companies: GE HealthCare Technologies Inc. (President and CEO, GE HealthCare · Since at least Dec 14, 2022); Bristol-Myers Squibb Company (Director · Since at least Apr 1, 2016); GE Aerospace (Senior Vice President · Jan 1, 2022 – Mar 1, 2022 · Past); SeaSpine Holdings Corp (President, Director · Jun 11, 2015 – Jun 11, 2015 · Past)
President & CEO, Director · May 22, 2013 – Sep 2, 2021 · Past
All 57 people
PersonSeat
Barbara B. Hill
Other companies: Omega Healthcare Investors, Inc. (Director · Since at least Apr 1, 2013); Accendra Health, Inc. (Director · Feb 9, 2017 – Jun 28, 2019 · Past); St. Jude Medical Inc (Director · Dec 6, 2007 – Jan 4, 2017 · Past)
Director · Since at least May 22, 2013
Carrie L. Anderson
Other companies: The Campbell's Company (Executive Vice President & CFO · Since at least Feb 6, 2023); Embecta Corp. (Director · Since at least Apr 1, 2022); Dover Corporation (Vice President and Controller · May 5, 2017 – Mar 15, 2019 · Past)
Executive Vice President & CFO · Jun 24, 2019 – Jul 1, 2022 · Past
Lloyd Howell Jr
Other companies: GE HealthCare Technologies Inc. (Director · Since at least Jan 3, 2023); Moody's Corporation (Director · Since at least Mar 15, 2021); Booz Allen Hamilton Holding Corporation (EVP & Chief Financial Officer · Jan 9, 2018 – Sep 9, 2022 · Past)
Director · May 17, 2018 – May 13, 2020 · Past
Michael Damon Hutchinson
Other companies: LivaNova PLC (SVP, CLO and Company Secretary · Since at least Nov 25, 2022); Varian Medical Systems Inc (SVP,Chief Legal Officer, Secy · Jun 1, 2020 – Apr 15, 2021 · Past); Stryker Corporation (VP, Chief Legal Officer · Apr 22, 2014 – Mar 21, 2019 · Past)
EVP, Chief Legal Officer & Sec · Since at least Jan 27, 2026
Dan Reuvers
Other companies: Neuronetics, Inc. (President & CEO · Since at least Mar 17, 2026); Tactile Systems Technology, Inc. (Director · Jun 8, 2020 – Mar 11, 2025 · Past)
CVP,PRES - CODMAN SPC SURGICAL · Dec 1, 2012 – May 11, 2020 · Past
Glenn Coleman
Other companies: Charles River Laboratories International, Inc. (Chief Financial Officer · Since at least Feb 18, 2026); Dentsply Sirona Inc. (Executive VP & CFO · Sep 26, 2022 – Oct 11, 2024 · Past)
Executive Vice President & COO · Nov 16, 2015 – Jul 1, 2022 · Past
Mark A Augusti
Other companies: ConforMIS Inc (FORMER PRESIDENT & CEO, Director · Nov 14, 2016 – Sep 5, 2023 · Past); Hutchinson Technology Inc (Director · Aug 16, 2010 – Feb 15, 2012 · Past)
CVP,PRES-ORTHO & TISSUE TECH · Apr 7, 2014 – Oct 7, 2016 · Past
Rhonda Germany Ballintyn
Other companies: Univar Inc (Director · Aug 1, 2017 – Aug 8, 2019 · Past); Aegion Corporation (Director · Jan 4, 2017 – May 17, 2021 · Past)
Director · Jan 9, 2019 – May 14, 2021 · Past
Eric Schwartz
Other companies: Globus Medical, Inc. (Senior VP and General Counsel · Mar 1, 2017 – Jun 25, 2018 · Past)
EVP, Chief Legal Officer & Sec · Nov 12, 2018 – Mar 11, 2025 · Past
James M Sullivan
Other companies: SeaSpine Holdings Corp (Director · May 30, 2018 – May 30, 2018 · Past)
Director · Mar 6, 2018 – May 17, 2018 · Past
Jan De Witte
Other companies: ResMed Inc. (Director · Since at least May 16, 2019)
President & CEO, Director · Dec 1, 2021 – Nov 1, 2024 · Past
Keith Bradley
Other companies: SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past)
Director · Since at least Feb 23, 2006
Lisa Evoli
Other companies: Catalent Inc (SVP, Chief HR Officer · Aug 23, 2023 – Dec 18, 2024 · Past)
EVP & CHRO · Jan 13, 2016 – Mar 10, 2023 · Past
Andrea CarusoCorporate Vice President and Chief Human Resources Officer · Since at least Nov 5, 2026
Brian LarkinCorp VP, Pres.Gbl Spine &Ortho · Dec 1, 2012 – Apr 2, 2015 · Past
Chantal Veillon-BertelootEVP & CHRO · Since at least Aug 23, 2023
Christopher Kilburn-PetersonCorporate Vice President and President, Tissue Reconstruction · Since at least Jun 23, 2026
Chris WardInvestor Relations · Since at least Oct 30, 2026
Deborah A LeonettiCorp VP, Glbl Servs & Repair · Jan 3, 2006 – May 8, 2015 · Past
Dimitri KvaresCorporate Vice President and Chief Information Officer · Since at least Nov 5, 2026
Gerard S CarlozziExecutive Vice President & COO · Jan 24, 2006 – Apr 1, 2010 · Past
Harvinder SinghExecutive Vice President and President, Specialty Surgery · Since at least Oct 3, 2022
Jeff GravesPresident, 3D Systems Corporation · Since at least Nov 4, 2026
Jeffrey MosebrookSVP, Fin & Princ Acct Officer · Since at least Oct 17, 2017
Jerry E CorbinCorp VP & Corporate Controller · Apr 2, 2007 – Jul 1, 2014 · Past
John MooradianCorp VP, Global Ops & Supp Chn · Dec 1, 2012 – Feb 13, 2020 · Past
Joseph VinhaisCorp VP,Quality&Transformation · May 9, 2016 – Sep 11, 2019 · Past
Judith OgradyCorpVP,Global Reg.Affairs · Apr 1, 2013 – Feb 13, 2020 · Past
Kenneth BurhopCORPVP,CHIEFSCIENTIFIC OFFICER · Mar 1, 2014 – Feb 13, 2020 · Past
Kerri DiPietroCorporate Vice President and Chief Quality Officer · Since at least Feb 17, 2026
Lea Daniels KnightExecutive Vice President and Chief Financial Officer · Since at least Jun 28, 2023
Lesha ShinnCorporate Vice President, Chief Legal Officer and Company Secretary · Since at least Sep 17, 2026
Michael McBreenExecutive Vice President and Chief Commercial Officer · Since at least Jun 8, 2020
Padma ThiruvengadamCorp VP, Chief HR Officer · Dec 1, 2012 – Apr 2, 2015 · Past
Raymond G MurphyDirector · May 24, 2016 – May 9, 2024 · Past
Raymond TurnerCorporate Vice President and Chief Medical Officer · Since at least Apr 7, 2026
Renee LoDirector · Since at least Jul 18, 2022
Richard D GorelickCorp VP, Gen Counsel & Sec · Dec 1, 2012 – Mar 23, 2018 · Past
Richard E CarusoDirector · Apr 27, 2006 – May 24, 2016 · Past
Rick MaveusSenior Vice President, Transformation and Program Management Office · Since at least May 5, 2025
Robert D PaltridgeCorp VP, Pres. Adv Woundcare · Dec 1, 2012 – Jul 1, 2014 · Past
Robert T. DavisExecutive Vice President and President, Tissue Reconstruction and Distributed Technologies · Since at least Jun 23, 2026
Robert T Davis JrEVP & President, TR&DT · Since at least Jul 24, 2019
Shaundra ClayDirector · Since at least Apr 1, 2021
Teshtar ElaviaCorporate Vice President and Chief Technology Officer · Since at least Feb 17, 2026
Topaz Joy KirlewCorporate Vice President and Chief Regulatory Officer · Since at least Jul 2, 2026
Valerie YoungCorporate Vice President, Global Supply Chain · Since at least May 5, 2025

Open People

Log in to ask 6ix AI your own questions about Integra LifeSciences Holdings Corporation.